Surface Functionalization of Single Superparamagnetic Iron Oxide Nanoparticles for Targeted Magnetic Resonance Imaging

被引:190
作者
Amstad, Esther [1 ]
Zurcher, Stefan [1 ]
Mashaghi, Alireza [1 ]
Wong, Joyce Y. [2 ]
Textor, Marcus [1 ]
Reimhult, Erik [1 ]
机构
[1] Swiss Fed Inst Technol, Lab Surface Sci & Technol, CH-8093 Zurich, Switzerland
[2] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA
关键词
functionalization; MRI; contrast agents; stabilization; targeting; QUARTZ-CRYSTAL MICROBALANCE; CONTRAST AGENTS; IN-VIVO; SHELL NANOPARTICLES; FE3O4; NANOPARTICLES; DEXTRAN; MRI; ATHEROSCLEROSIS; MACROMOLECULES; ADSORPTION;
D O I
10.1002/smll.200801328
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Magnetic resonance imaging (MRI), a non-invasive, non-radiative technique, is thought to lead to cellular or even molecular resolution if optimized targeted MR contrast agents are introduced. This would allow diagnosing progressive diseases in early stages. Here, it is shown that the high binding affinity of poly(ethylene glycol)-gallol (PEG-gallol) allows freeze drying and re-dispersion of 9 +/- 2-nm iron oxide cores individually stabilized with approximate to 9-nm-thick stealth coatings, yielding particle stability for at least 20 months. Particle size, stability, and magnetic properties of PEGylated particles are compared to Feridex, a commercially available untargeted negative MR contrast agent. Biotin-PEG (3400)-gallol/methoxy-PEG (550) gallol stabilized nanoparticles are further functionalized with biotinylated human anti-VCAM-1 antibodies using the biotin-neutravidin linkage. Binding kinetics and excellent specificity of these nanoparticles are demonstrated using quartz crystal microbalance with dissipation monitoring (QCM-D). These MR contrast agents can be functionalized with any biotinylated ligand at controlled ligand surface density, rendering them a versatile research tool.
引用
收藏
页码:1334 / 1342
页数:9
相关论文
共 51 条
  • [1] BACON BR, 1987, J LAB CLIN MED, V110, P164
  • [2] MAGNETITE FE3O4(111) - SURFACE-STRUCTURE BY LEED CRYSTALLOGRAPHY AND ENERGETICS
    BARBIERI, A
    WEISS, W
    VANHOVE, MA
    SOMORJAI, GA
    [J]. SURFACE SCIENCE, 1994, 302 (03) : 259 - 279
  • [3] Comparative study of ferrofluids based on dextran-coated iron oxide and metal nanoparticles for contrast agents in magnetic resonance imaging
    Bautista, MC
    Bomati-Miguel, O
    Zhao, X
    Morales, MP
    González-Carreño, T
    de Alejo, RP
    Ruiz-Cabello, J
    Veintemillas-Verdaguer, S
    [J]. NANOTECHNOLOGY, 2004, 15 (04) : S154 - S159
  • [4] INFLUENCE OF CRYSTALLITE SIZE ON MAGNETIC PROPERTIES OF ACICULAR GAMMA-FE2O3 PARTICLES
    BERKOWIT.AE
    SCHUELE, WJ
    FLANDERS, PJ
    [J]. JOURNAL OF APPLIED PHYSICS, 1968, 39 (2P2) : 1261 - &
  • [5] Adsorption of gases in multimolecular layers
    Brunauer, S
    Emmett, PH
    Teller, E
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1938, 60 : 309 - 319
  • [6] Molecular, cellular and functional imaging of atherothrombosis
    Choudhury, RP
    Fuster, V
    Fayad, ZA
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (11) : 913 - 925
  • [7] Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution
    Chouly, C
    Pouliquen, D
    Lucet, I
    Jeune, JJ
    Jallet, P
    [J]. JOURNAL OF MICROENCAPSULATION, 1996, 13 (03) : 245 - 255
  • [8] Cornell R. M, 2003, IRON OXIDES
  • [9] A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
    Cybulsky, MI
    Iiyama, K
    Li, HM
    Zhu, SN
    Chen, M
    Iiyama, M
    Davis, V
    Gutierrez-Ramos, JC
    Connelly, PW
    Milstone, DS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (10) : 1255 - 1262
  • [10] Protein resistance of titanium oxide surfaces modified by biologically inspired mPEG-DOPA
    Dalsin, JL
    Lin, LJ
    Tosatti, S
    Vörös, J
    Textor, M
    Messersmith, PB
    [J]. LANGMUIR, 2005, 21 (02) : 640 - 646